Tenet Healthcare (NYSE: THC) reported Q1 EPS of a loss $0.52, $0.01 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $4.85 billion versus the consensus estimate of $4.84 billion.

GUIDANCE:

Tenet Healthcare sees Q2 2017 revenue of $4.85-5.05 billion, versus the consensus of $4.89 billion.

Sees FY 2017 Adj. Cont. Ops. EPS of $1.05-1.30 versus consensus of $1.15, revenues of $19.7-$20.1 billion versus consensus of $19.81 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.